Grothey, Bastian ORCID: 0000-0002-0883-6481, Lyu, Su Ir ORCID: 0009-0002-4125-6048, Quaas, Alexander ORCID: 0000-0002-3537-6011, Simon, Adrian Georg ORCID: 0000-0002-2709-863X, Jung, Jin-On ORCID: 0000-0001-6121-0114, Schröder, Wolfgang ORCID: 0000-0002-8700-069X, Bruns, Christiane J. ORCID: 0000-0001-6590-8181, Schiffmann, Lars M. ORCID: 0000-0002-2320-5004, Popp, Felix C. ORCID: 0000-0002-1690-6777, Schmidt, Thomas ORCID: 0000-0002-7166-3675 and Knipper, Karl ORCID: 0009-0008-7133-3538 (2025). Proteomic characterization of MET-amplified esophageal adenocarcinomas reveals enrichment of alternative splicing- and androgen signaling-related proteins. Cellular and Molecular Life Sciences, 82 (1). pp. 1-13. Springer Nature. ISSN 1420-9071

[thumbnail of s00018-025-05635-7.pdf] PDF
s00018-025-05635-7.pdf
Bereitstellung unter der CC-Lizenz: Creative Commons Attribution.

Download (2MB)
Identification Number:10.1007/s00018-025-05635-7

Abstract

[Article No. 112] Background: Esophageal adenocarcinomas (EACs) represent an evolving tumor entity with high mortality rates. MET amplification is a recurrent driver in EACs and is associated with decreased patient survival. However, the response to MET inhibitors is limited. Recent studies have identified several mechanisms that lead to resistance against MET inhibitors in different tumor entities. Nonetheless, a characterization of additional vulnerable targets beyond MET has not been conducted in MET-amplified EACs. Methods: In this study, we determined the MET amplification status in a cohort of more than 900 EACs using fluorescence in situ hybridization (FISH) and compared the proteomes of MET-amplified ( n = 20) versus non-amplified tumors ( n = 39) by mass spectrometry. Results: We identified a phenotype, present in almost all MET-amplified tumors, which shows an enrichment of alternative RNA splicing, and androgen receptor signaling proteins, as well as decreased patient survival. Additionally, our analyses revealed a negative correlation between MET expression and patient survival in MET-amplified EACs, indicating biological heterogeneity with clinical relevance despite the presence of MET amplification as the predominant oncogenic driver. Furthermore, quantitative immunohistochemical analysis of the inflammatory tumor microenvironment showed that an increased percentage of M2 macrophages is associated with lower overall survival in MET-amplified EACs. Conclusions: Our results provide valuable insights into possible new therapeutic approaches for MET-amplified EACs for further research.

Item Type: Article
Creators:
Creators
Email
ORCID
ORCID Put Code
Grothey, Bastian
UNSPECIFIED
UNSPECIFIED
Lyu, Su Ir
UNSPECIFIED
UNSPECIFIED
Quaas, Alexander
UNSPECIFIED
UNSPECIFIED
Simon, Adrian Georg
UNSPECIFIED
UNSPECIFIED
Jung, Jin-On
UNSPECIFIED
UNSPECIFIED
Schröder, Wolfgang
UNSPECIFIED
UNSPECIFIED
Bruns, Christiane J.
UNSPECIFIED
UNSPECIFIED
Schiffmann, Lars M.
UNSPECIFIED
UNSPECIFIED
Popp, Felix C.
UNSPECIFIED
UNSPECIFIED
Schmidt, Thomas
UNSPECIFIED
UNSPECIFIED
Knipper, Karl
UNSPECIFIED
UNSPECIFIED
URN: urn:nbn:de:hbz:38-792965
Identification Number: 10.1007/s00018-025-05635-7
Journal or Publication Title: Cellular and Molecular Life Sciences
Volume: 82
Number: 1
Page Range: pp. 1-13
Date: 13 March 2025
Publisher: Springer Nature
ISSN: 1420-9071
Language: English
Faculty: Faculty of Medicine
Divisions: Faculty of Medicine > Chirurgie > Klinik und Poliklinik für Allgemein-, Viszeral- und Tumorchirurgie
Faculty of Medicine > Pathologie und Neuropathologie > Institut für Pathologie
Faculty of Medicine > Sonstiges > Centrum für integrierte Onkologie (CIO)
Subjects: Medical sciences Medicine
['eprint_fieldname_oa_funders' not defined]: Publikationsfonds UzK
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/79296

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item